Kalantaridou SN, Calis KA, Vanderhoof VH, Bakalov VK, Corrigan EC, Troendle JF, Nelson LM. Testosterone deficiency in young women with 46,XX spontaneous premature ovarian failure.
Fertil Steril 2006;
86:1475-82. [PMID:
17070197 DOI:
10.1016/j.fertnstert.2006.04.028]
[Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2006] [Revised: 04/12/2006] [Accepted: 04/12/2006] [Indexed: 11/18/2022]
Abstract
OBJECTIVE
To determine whether women with 46,XX spontaneous premature ovarian failure have lower serum free-T levels than do control women.
DESIGN
Cross-sectional.
SETTING
National Institutes of Health Clinical Research Center.
PATIENT(S)
Women with 46,XX spontaneous premature ovarian failure (n = 130).
INTERVENTION(S)
Evaluation while off any estrogen therapy and then again after receiving a standardized hormone regimen. Regularly menstruating control women (n = 65) were sampled during the midfollicular phase.
MAIN OUTCOME MEASURE(S)
Serum total T by RIA after extraction and column chromatography, free T by equilibrium dialysis, and sex hormone-binding globulin by immunoradiometric assay.
RESULT(S)
While off estrogen therapy patients had a median serum free-T concentration that was statistically significantly lower than controls (2.2 vs. 3.3 pg/mL). This dropped significantly lower to 1.9 pg/mL while the patients were on physiologic transdermal E(2) therapy. This is despite the fact that sex hormone-binding globulin levels did not change. While on E(2) therapy, 13% of women (95% confidence interval, 7.9%-20.3%) had serum free-T levels below the lower limit of normal (<1.1 pg/mL).
CONCLUSION(S)
As a group, young women with 46,XX spontaneous premature ovarian failure have reduced circulating free-T levels, both during an interval off of estrogen therapy and while on physiologic transdermal E(2) therapy.
Collapse